Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
CC transcript
Appointed director
MANNKIND CORP (MNKD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2023 SECOND QUARTER FINANCIAL RESULTS"
06/30/2023 8-K Other Events  Interactive Data
05/09/2023 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2023 FIRST QUARTER FINANCIAL RESULTS"
03/27/2023 8-K Quarterly results
02/23/2023 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m."
11/08/2022 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2022 THIRD QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 9:00 a.m."
10/31/2022 8-K Quarterly results
09/26/2022 8-K Other Events  Interactive Data
08/09/2022 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2022 SECOND QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m."
05/25/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
01/18/2022 8-K Other Events  Interactive Data
12/27/2021 8-K Other Events  Interactive Data
11/09/2021 8-K Quarterly results
Docs: "MANNKIND CORPORATION REPORTS 2021 THIRD QUARTER FINANCIAL RESULTS Conference Call to Begin Today at 5:00 p.m."
10/18/2021 8-K Entry into a Material Definitive Agreement, Other Events  Interactive Data
09/29/2021 8-K Quarterly results
08/16/2021 8-K/A Quarterly results
08/13/2021 8-K Quarterly results
08/11/2021 8-K Quarterly results
06/16/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
05/25/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
04/26/2021 8-K Quarterly results
03/05/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
12/30/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Omnibus Joinder and Amendment No. 5 to Credit and Security Agreement and Amendment No. 1 to Pledge Agreement, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust",
"Omnibus Joinder and Amendment No. 5 to Credit and Security Agreement and Amendment No. 1 to Pledge Agreement, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust"
12/10/2020 8-K Other Events  Interactive Data
12/07/2020 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Purchase Agreement, by and among the Company, the Acquired Company, the Sellers and the Securityholders’ Representative",
"Amendment No. 4 to Credit and Security Agreement, by and among the Company, MannKind LLC and MidCap Financial Trust",
"MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc."
12/01/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amendment No. 3 to Credit and Security Agreement, by and among MannKind Corporation, MannKind LLC and MidCap Financial Trust",
"Amendment No. 3 to Credit and Security Agreement, by and among MannKind Corporation, MannKind LLC and MidCap Financial Trust"
11/30/2020 8-K Appointed a new director
11/04/2020 8-K Quarterly results
Docs: "3Q 2020 U.S. Afrezza Net Revenue of $7.3 million; +27% vs. 3Q 2019 • 3Q YTD 2020 U.S. Afrezza Net Revenue of $22.1 million; +31% vs. 3Q YTD 2019 • Cash and cash equivalents of $52.4 million at September 30, 2020 • On track to complete Treprostinil Technosphere development activities in 4Q 2020 • Expanded Afrezza commercial and medical teams • YTD Afrezza scientific presentations and publications total 14"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy